BridgeBio

Palo Alto, United States

BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.

Jan 2026

Post-IPO Debt

Top Investors

Sequoia CapitalPerceptive AdvisorsBlue OwlHercules CapitalKohlberg Kravis Roberts & Co.

19,000+ verified contacts

Emails, phones & LinkedIn profiles

Who are BridgeBio's investors?

BridgeBio's investors include Sequoia Capital, Perceptive Advisors, Blue Owl, Hercules Capital, Kohlberg Kravis Roberts & Co..

Where is BridgeBio headquartered?

BridgeBio is headquartered in Palo Alto, United States.

What does BridgeBio do?

BridgeBio focuses on the development and commercialization of precision medicines for various genetic diseases and cancers.

What stage is BridgeBio at?

BridgeBio is at the Post-IPO Debt stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated January 16, 2026.

MLA

"BridgeBio — Funding & Investors." VCBacked, January 16, 2026, https://www.vcbacked.co/company/bridgebio. Accessed July 1, 2026.

APA

VCBacked. (2026). BridgeBio — Funding & Investors. Retrieved July 1, 2026, from https://www.vcbacked.co/company/bridgebio

Wikipedia (cite web)

{{cite web |title=BridgeBio — Funding & Investors |url=https://www.vcbacked.co/company/bridgebio |website=VCBacked |access-date=July 1, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated January 16, 2026.